Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fusarium mycotoxins, commonly known as fusariotoxins, are a diverse group of secondary metabolites produced by fungi of the genus Fusarium, which frequently contaminate agricultural crops such as wheat, maize, and barley (Source: WHO, 2018). This group includes several chemically distinct classes, most notably trichothecenes (e.g., deoxynivalenol and T-2 toxin), zearalenone, and fumonisins, each possessing unique toxicological profiles (Source: EFSA, 2017). These compounds are not therapeutic targets but are potent environmental toxicants that disrupt essential cellular functions. Trichothecenes exert toxicity by binding to the 60S ribosomal subunit and inhibiting protein synthesis, while zearalenone acts as a competitive agonist for estrogen receptors, and fumonisins inhibit the enzyme ceramide synthase (Source: PubMed, PMID: 21839735; NIH, 2020). Exposure to these toxins is linked to a variety of human and animal health issues, including acute gastrointestinal distress, esophageal cancer, and reproductive disorders. Because they are xenobiotics rather than drug targets, pharmacological management is generally limited to the use of sequestering agents like activated charcoal or specialized clay minerals to prevent intestinal absorption (Source: Journal of Animal Science and Biotechnology, 2013). Research in this field primarily focuses on agricultural mitigation and food safety monitoring rather than drug development.
Therapeutic intervention primarily involves the use of non-specific adsorbent agents that physically bind the toxins within the gastrointestinal tract, thereby preventing their systemic absorption and reducing bioavailability.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fusarium mycotoxins (Fusariotoxins).